Detalhe da pesquisa
1.
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria.
Malar J
; 22(1): 2, 2023 Jan 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36597076
2.
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria.
Malar J
; 20(1): 222, 2021 May 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-34011358
3.
Characterising the blood-stage antimalarial activity of pyronaridine in healthy volunteers experimentally infected with Plasmodium falciparum.
Int J Antimicrob Agents
; 64(1): 107196, 2024 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38734217
4.
Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria.
Am J Trop Med Hyg
; 108(1): 81-84, 2023 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36509063
5.
Community-based management of a five-arm randomised clinical trial in COVID-19 outpatients in South Africa: challenges and opportunities.
Trials
; 24(1): 635, 2023 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794489
6.
Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre, parallel-group, randomised, controlled, phase 2 trial.
Lancet Infect Dis
; 23(9): 1051-1061, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327809
7.
Safety and efficacy of four drug regimens versus standard-of-care for the treatment of symptomatic outpatients with COVID-19: A randomised, open-label, multi-arm, phase 2 clinical trial.
EBioMedicine
; 86: 104322, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36332361
8.
Deploying artemether-lumefantrine with rapid testing in Ethiopian communities: impact on malaria morbidity, mortality and healthcare resources.
Trop Med Int Health
; 15(2): 241-50, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19961564
9.
The effect of food consumption on lumefantrine bioavailability in African children receiving artemether-lumefantrine crushed or dispersible tablets (Coartem) for acute uncomplicated Plasmodium falciparum malaria.
Trop Med Int Health
; 15(4): 434-41, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20180933
10.
Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?
Malar J
; 9: 30, 2010 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-20096111
11.
Cadazolid for the treatment of Clostridium difficile infection: results of two double-blind, placebo-controlled, non-inferiority, randomised phase 3 trials.
Lancet Infect Dis
; 19(3): 265-274, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30709665
12.
Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.
Ann N Y Acad Sci
; 1222: 19-29, 2011 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-21434939
13.
Efficacy and safety of artemether-lumefantrine in the treatment of acute, uncomplicated Plasmodium falciparum malaria: a pooled analysis.
Am J Trop Med Hyg
; 85(5): 793-804, 2011 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22049029